Large gap with delayed quotes
|
Last quote
05/08/2025 -
17:31:25
|
Bid
05/09/2025 -
08:47:08
|
Bid Volume |
Ask
05/09/2025 -
08:47:08
|
Ask Volume |
|---|---|---|---|---|
|
3.365
-0.005
(
-0.15% )
|
3.20
|
2,000 |
3.93
|
850 |
Analysis date: 06.05.2025
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 25.04.2025.
Interest
Very weak
Very weak
One star since 06.05.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 14.03.2025 at a price of 3.69.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 17.01.2025.
4wk Rel Perf
2.35%
2.35%
The four-week dividend-adjusted overperformance versus STOXX600 is 2.35%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.48%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.85%.
Mkt Cap in $bn
0.17
0.17
With a market capitalization <$2bn, MOLECULAR PARTNERS is considered a small-cap stock.
G/PE Ratio
-6.49
-6.49
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-1.31
-1.31
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-8.48%
-8.48%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
21
21
For 1% of index variation, the stock varies on average by 0.21%.
Correlation
0.04
0.04
Stock movements are totally independent of index variations.
Value at Risk
2.16
2.16
The value at risk is estimated at CHF 2.16. The risk is therefore 62.34%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
12.08.2016
12.08.2016